The DOI matches its Crossref record; 57 of the 63 references it cites were found in a registry or an index.
p300/MDM2 Complexes Participate in MDM2-Mediated p53 Degradation
Open accessAbstract
Control of p53 turnover is critical to p53 function. E1A binding to p300/CBP translates into enhanced p53 stability, implying that these coactivator proteins normally operate in p53 turnover control. In this regard, the p300 C/H1 region serves as a specific in vivo binding site for both p53 and MDM2, a naturally occurring p53 destabilizer. Moreover, most of the endogenous MDM2 is bound to p300, and genetic analysis implies that specific interactions of p53 and MDM2 with p300 C/H1 are important steps in the MDM2-directed turnover of p53. A specific role for p300 in endogenous p53 degradation is underscored by the p53-stabilizing effect of overproducing the p300 C/H1 domain. Taken together, the data indicate that specific interactions between p300/CBP C/H1, p53, and MDM2 are intimately involved in the MDM2-mediated control of p53 abundance.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, both Mdm2 and Mdmx interact with many other proteins, including those involved in development, morphogenesis and tumorigenesis (Table 2; [81–92]).”
From The p53 orchestra: Mdm2 and Mdmx set the tone (2010) · cites this paper as [87]
Citations
Cites
p53, the cellular gatekeeper for growth and division
Levine, A. J. (1997) · Cell · doi:10.1016/s0092-8674(00)81871-1 · Cited by 7,693
High-Efficiency Transformation of Mammalian Cells by Plasmid DNA
Chen, C., & Okayama, H. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.8.2745 · Cited by 5,327
Mdm2 promotes the rapid degradation of p53
Haupt, Y., Maya, R., Kazaz, A., & Oren, M. (1997) · Nature · doi:10.1038/387296a0 · Cited by 4,506
The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53
Scheffner, M., Werness, B. A., Huibregtse, J. M., Levine, A. J., & Howley, P. M. (1990) · Cell · doi:10.1016/0092-8674(90)90409-8 · Cited by 3,995
Self-citationRegulation of p53 stability by Mdm2
Kubbutat, M. H. G., Jones, S. N., & Vousden, K. H. (1997) · Nature · doi:10.1038/387299a0 · Cited by 3,312
Momand, J., Zambetti, G. P., Olson, D. C., George, D., & Levine, A. J. (1992) · Cell · doi:10.1016/0092-8674(92)90644-r · Cited by 3,113
The Transcriptional Coactivators p300 and CBP Are Histone Acetyltransferases
Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., & Nakatani, Y. (1996) · Cell · doi:10.1016/s0092-8674(00)82001-2 · Cited by 2,952
Activation of p53 Sequence-Specific DNA Binding by Acetylation of the p53 C-Terminal Domain
Gu, W., & Roeder, R. G. (1997) · Cell · doi:10.1016/s0092-8674(00)80521-8 · Cited by 2,559
The HPV-16 E6 and E6-AP complex functions as a ubiquitin-protein ligase in the ubiquitination of p53
Scheffner, M., Huibregtse, J. M., Vierstra, R. D., & Howley, P. M. (1993) · Cell · doi:10.1016/0092-8674(93)90384-3 · Cited by 2,416
Self-citationp53: puzzle and paradigm.Preprint
Ko, L. J., & Prives, C. L. (1996) · Genes & Development · doi:10.1101/gad.10.9.1054 · Cited by 2,346
Cited by
Sorted by citations
Items 401–412 of 412
Targeting MDM2, the antagonist of the tumor suppressor p53
Sriraman, A. (2018) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-7056
Gerber, S. (2020) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-8184
Clifford, A., Kelly, C., Yau, C., & Hallam, S. (2012) · CRC Press eBooks · doi:10.1201/b13289-21
Pinning Control to Regulate Cellular Response in Cancer for the p53-Mdm2 Genetic Regulatory Network
Suárez, O. J., Vega, C. J., Sanchez, E. N., Chen, G., Santiago, A. E. G., Rodríguez-Jorge, O., Alanís, A. Y., & Hernandez-Vargas, E. A. (2022) · Emergence, complexity and computation · doi:10.1007/978-3-031-04379-6_6
Kubiak, K. (2023) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-9838
Discovery of niclosamide as a p300/transcription factor protein–protein interaction inhibitor
Fitriastuti, D., Miura, K., Okada, S., Hirano, H., Osada, H., & Nakamura, H. (2025) · Bioorganic & Medicinal Chemistry · doi:10.1016/j.bmc.2025.118114
Novel concepts in MDM2 protein regulation
Worrall, E. G. (2009) · ERA
Mutant p53 gains RNA-binding activity to reprogram translation and mitochondrial function
Zhou, W., Long, A., Douglas, C. J., Gallegos, D., Burke, J. M., MacMillan, D. W. C., Hacisuleyman, E., & Seath, C. P. (2026) · Cell Reports · doi:10.1016/j.celrep.2026.117856 · Cited by 1
Shi, D. (2010) · The Journal of the American Medical Association (JAMA) Network (American Medical Association) · doi:10.13028/hfsb-j486
The regulation of p53-dependent microRNA expression in response to genotoxic stress
Purmessur, N. S. (2014) · Figshare
Metadata
- Authors
- Grossman, S. R., Perez, M., Kung, A. L., Joseph, M., Mansur, C., Xiao, Z.-X., Kumar, S., Howley, P. M., & Livingston, D. M.
- Affiliations
- Harvard University (US)
- Tufts University (US)
- Boston University (US)
- Corresponding author
- Livingston, David M
- ORCID
- Venue
- Molecular Cell
- Publisher
- Elsevier BV
- Published
- 1998-10
- Volume
- 2
- Issue
- 4
- Pages
- 405-415
- ISSN
- 1097-2765 (ISSN-L)
- OpenAlex
- W2063877452
- Cited by
- 414
- References
- 63
- Citations by year
- 2026: 2 · 2025: 4 · 2024: 3 · 2023: 7 · 2022: 7 · 2021: 4 · 2020: 9 · 2019: 4 · 2018: 6 · 2017: 2 · 2016: 9 · 2015: 4 · 2014: 15 · 2013: 15 · 2012: 18
- FWCI
- 19.07
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Molecular Cell (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Ubiquitin and proteasome pathways
- Keywords
- P300, MDM2, p53 degradation, CBP, adenovirus E1A, protein-protein interaction, p53 stabilization, tumor suppressor regulation
- MeSH terms
- Cell Line, DNA-Binding Proteins, Humans, Molecular Sequence Data, Neoplasm Proteins, Nuclear Proteins, Oncogene Proteins, Viral, Protein Binding, Proto-Oncogene Proteins, Ubiquitins, Trans-Activators, Tumor Suppressor Protein p53, Mutagenesis, Sequence Homology, Amino Acid, Proto-Oncogene Proteins c-mdm2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
